These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23155288)

  • 1. Feasibility of (18)F-fluorodeoxyglucose positron-emission tomography for preoperative evaluation of biliary tract cancer.
    Yamada I; Ajiki T; Ueno K; Sawa H; Otsubo I; Yoshida Y; Shinzeki M; Toyama H; Matsumoto I; Fukumoto T; Nakao A; Kotani J; Ku Y
    Anticancer Res; 2012 Nov; 32(11):5105-10. PubMed ID: 23155288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography in detection and presurgical assessment of pancreatic cancer: a prospective study.
    Buchs NC; Bühler L; Bucher P; Willi JP; Frossard JL; Roth AD; Addeo P; Rosset A; Terraz S; Becker CD; Ratib O; Morel P
    J Gastroenterol Hepatol; 2011 Apr; 26(4):657-62. PubMed ID: 21155879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of fluorodeoxyglucose PET imaging in the diagnosis of malignancies in patients with biliary stricture.
    Wakabayashi H; Akamoto S; Yachida S; Okano K; Izuishi K; Nishiyama Y; Maeta H
    Eur J Surg Oncol; 2005 Dec; 31(10):1175-9. PubMed ID: 16019182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic importance of standardized uptake value on F-18 fluorodeoxyglucose-positron emission tomography in biliary tract carcinoma.
    Furukawa H; Ikuma H; Asakura K; Uesaka K
    J Surg Oncol; 2009 Nov; 100(6):494-9. PubMed ID: 19653260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Impact of positron emission tomography on clinical management of potentially resectable non-small-cell lung cancer: a French prospective multicenter study].
    Margery J; Milleron B; Vaylet F; Grahek D; Lebeau B; Mangiapan G; Bonardel G; de Labriolle-Vaylet C; Meignan M; Carette MF; Talbot JN; Housset B
    Rev Pneumol Clin; 2010 Oct; 66(5):313-20. PubMed ID: 21087727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer.
    Kato T; Tsukamoto E; Kuge Y; Katoh C; Nambu T; Nobuta A; Kondo S; Asaka M; Tamaki N
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1047-54. PubMed ID: 12173019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of (18)F-2-deoxy-fluoro-D-glucose positron emission tomography for pN2 lymph nodes in patients with lung cancer.
    Ozawa Y; Hara M; Sakurai K; Nakagawa M; Tamaki T; Nishio M; Shibamoto Y
    Acta Radiol; 2010 Mar; 51(2):150-5. PubMed ID: 20092375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the diagnostic value of (18)F-FDG PET-CT and enhanced CT for staging of lymph node metastasis in non-small cell lung cancer].
    Yang WF; Tan GZ; Fu Z; Yu JM
    Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):925-8. PubMed ID: 20193335
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Lamarca A; Barriuso J; Chander A; McNamara MG; Hubner RA; ÓReilly D; Manoharan P; Valle JW
    J Hepatol; 2019 Jul; 71(1):115-129. PubMed ID: 30797051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of FDG-PET for lymph node metastasis and outcome of surgery for biliary cancer.
    Kobayashi S; Nagano H; Hoshino H; Wada H; Marubashi S; Eguchi H; Takeda Y; Tanemura M; Kim T; Shimosegawa E; Hatazawa J; Doki Y; Mori M
    J Surg Oncol; 2011 Mar; 103(3):223-9. PubMed ID: 21140426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node metastasis diagnosis using positron emission tomography with 2-[18F] fluoro-2-deoxy-D-glucose as a tracer and computed tomography in surgical cases of non-small cell lung cancer.
    Ose N; Sawabata N; Minami M; Inoue M; Shintani Y; Kadota Y; Okumura M
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):89-92. PubMed ID: 22290887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer.
    Corvera CU; Blumgart LH; Akhurst T; DeMatteo RP; D'Angelica M; Fong Y; Jarnagin WR
    J Am Coll Surg; 2008 Jan; 206(1):57-65. PubMed ID: 18155569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
    Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
    Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
    Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients.
    Takamochi K; Yoshida J; Murakami K; Niho S; Ishii G; Nishimura M; Nishiwaki Y; Suzuki K; Nagai K
    Lung Cancer; 2005 Feb; 47(2):235-42. PubMed ID: 15639722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer.
    Kluge R; Schmidt F; Caca K; Barthel H; Hesse S; Georgi P; Seese A; Huster D; Berr F
    Hepatology; 2001 May; 33(5):1029-35. PubMed ID: 11343227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography.
    Chang JT; Chan SC; Yen TC; Liao CT; Lin CY; Lin KJ; Chen IH; Wang HM; Chang YC; Chen TM; Kang CJ; Ng SH
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):501-7. PubMed ID: 15890593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative 18F-FDG PET-CT maximum standardized uptake value predicts recurrence of biliary tract cancer.
    Park MS; Lee SM
    Anticancer Res; 2014 May; 34(5):2551-4. PubMed ID: 24778075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.